Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Intravenous pamidronate treatment improves growth in prepubertal osteogenesis imperfecta patients.

Authors
  • Heino, Terhi J
  • Aström, Eva
  • Laurencikas, Evaldas
  • Sävendahl, Lars
  • Söderhäll, Stefan
Type
Published Article
Journal
Hormone Research in Paediatrics
Publisher
S. Karger AG
Publication Date
Jan 01, 2011
Volume
75
Issue
5
Pages
354–361
Identifiers
DOI: 10.1159/000323370
PMID: 21304249
Source
Medline
License
Unknown

Abstract

Monthly pamidronate improves the growth of prepubertal patients with mild OI, where the most prominent growth stimulation is seen in the upper body segment.

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. This record was last updated on 07/04/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM. The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/21304249
Report this publication

Statistics

Seen <100 times